header
Image from OpenLibrary

Phase II study of low dose fixed rate infusion of gemcitabine with cisplatin and dexamethazone in resistant non- hodgkin lymphoma and correlation with MDR and BCL -2 expression / Shereef Ahmed Elsammany ; Supervised Mostafa Mahmoud Elserafy , Sameh Sayed Ahmed Shamaa , Mona Ali Sakr

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Shereef Ahmed Elsammany , 2010Description: 202P. : charts ; 25cmOther title:
  • دراسة الاستجابة للتنقيط الوريدى ذو المعدل الثابت لعقار الجمستابين مع السيزبلاتين و الديكساميثازون فى حالات الليمفوما من نوع غير الهودحكين غير المستجيبة للعلاج الكيميائى و علاقة وجود جين م.د.ر و جين ب س ل2 بالاستجابة لهذا البرنامج العلاجى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical Summary: Despite significant advances in the managment of patients with aggressive non - hodgkin's lymphomas (NHLs) significant proportion of patients still experience relapse following initial response to therapy or even not responding to chemotherapy from the start . So there is a great priority for the development of new chemotherapy regimens in addition to new prognostic factors for respone and survival in patients with resistant disease
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2010.Sh.P (Browse shelf(Opens below)) Not for loan 01010110054416000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.19.04.Ph.D.2010.Sh.P (Browse shelf(Opens below)) 54416.CD Not for loan 01020110054416000

Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical

Despite significant advances in the managment of patients with aggressive non - hodgkin's lymphomas (NHLs) significant proportion of patients still experience relapse following initial response to therapy or even not responding to chemotherapy from the start . So there is a great priority for the development of new chemotherapy regimens in addition to new prognostic factors for respone and survival in patients with resistant disease

Issued also as CD

There are no comments on this title.

to post a comment.